We frequently serve as trial and national coordinating counsel to pharmaceutical and medical device companies in large-scale serial litigation and mass torts. Our clients look to us to defend high-profile cases in difficult jurisdictions and to craft creative solutions that reach beyond the usual playbook to provide effective, efficient defenses.
Our product liability team has a command of the unique regulatory and legal issues facing pharmaceutical and medical device companies. We advise clients on product safety recalls, regulatory inquiries, and litigation before regulatory agencies. Our lawyers have been at the forefront of the rapidly developing law in this area, including having successfully defended numerous cases on the basis of federal preemption that established important precedents in key jurisdictions.
Our product liability lawyers collaborate with colleagues on our white collar, government investigations, and FDA teams to provide comprehensive, closely coordinated approaches. We pride ourselves on our culture of working with others to maximize the success of our client-focused defenses. Where it benefits the client, we also have the ability to partner with other leading law firms as part of a virtual law firm team to bring additional strategic resources to bear.
In addition, we regularly counsel pharmaceutical and medical device companies on strategies to prevent and reduce exposure and risk, including conducting audits of labeling and marketing materials to ensure compliance with relevant statutes.
Beyond pharmaceuticals and medical devices, Morgan Lewis has decades of experience handling class actions and national serial litigation involving the full range of state and federal causes of action—including those related to products regularly implicated in bodily injury, personal injury, and tort litigation such as chemicals, asbestos, blood, carpets, lead, latex, and building and construction products.
Source URL: Read More
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.
Acquire this Domain
You can acquire this site’s domain name! We have nurtured its online marketing value by systematically curating this site by the domain’s relevant keywords. Explore our content network – you can advertise on each or rent vs. buy the domain. Buy@TLDtraders.com | Skype: TLDtraders | +1 (475) BUY-NAME (289 – 6263). Thousands search by this site’s exact keyword domain name! Most are sent here because search engines often love the keyword. This domain can be your 24/7 lead generator! If you own it, you could capture a large amount of online traffic for your niche. Stop wasting money on ads. Instead, buy this domain to gain a long-term marketing asset. If you can’t afford to buy then you can rent the domain.
We are Internet Investors, Developers, and Franchisers – operating a content network of several thousand sites while federating 100+ eCommerce and SaaS startups. With our proprietary “inverted incubation” model, we leverage a portfolio of $100M in valued domains to impact online trends, traffic, and transactions. We use robotic process automation, machine learning, and other proprietary approaches to power our content network. Contact us to learn how we can help you with your online marketing and/or site maintenance.